Nacario's Digital Scrapbook

• Mortality rate of advanced breast cancer has decreased 50% thanks too newer forms of chemotherapy.
  
• An anthracycline drug has led to a 22% reduction in risks of death versus older technology that used nonanthracycline drugs. These drugs are similar to antibiotics and attack the genetic material of a cancer cell.
  
• Another drug called taxanes have lowered chances of death by 33% and new combos of taxanes have reduced death risks by 51%. Taxanes interfere with the mitosis of cancer.
  
• The analysis was comprised of 148 comparisons, 122 trials with 26,031 patients using 22 different types of therapy.
• Incorporating these new treatments together can result with greater chances of survival with people with advanced breast cancer.

• This article relates to our Cancer section and is relevant because of the new treatments that are available and how people can combat cancer.

My take on this article is very positive. if my grandmother was alive today and had these options to maintain her cancer, maybe she would still be around. Hearing these news is spectacular because treatments like taxanes can vastly increase a person's chance of survival. My concern on this is that it is a new treatment and most likely has a heavy bill to pay off. That and I am concerned if an advanced cancer can adapt to these newer treatments, making them immune, and the whole drug useless. I agree that instead of single treatments on one therapy is insufficient and multiple treatments must be used to have an effective regimen against cancer.

http://www.youtube.com/watch?v=Z_qKG_R9FHQ&feature=player_embedded